
    
      Patients with chronic stenotic or occlusive atherosclerotic disease and lesions of at least
      13 cm length in the SFA or Arteria poplitea segment 1 will be randomized to either treatment
      with paclitaxel coated balloon catheter, paclitaxel coated stent or bare nitinol stent.
      Vessel patency will be evaluated by quantitative angiography after 12 months. Clinical
      follow-ups will be done until 36 months post-intervention.
    
  